The IndiTreat® Test matches the individual cancer patient with the most effective cancer treatment.
Current cancer entities:
Colorectal cancer – Ovarian Cancer – Pancreatic Cancer
From a small tissue sample (primary tumor or metastasis) we generate thousands of 3D micro-tumors (tumoroids) that have the same properties as the tumor/metastasis in the individual patient. The tumoroids are challenged with single drugs or drug-combinations. Immediately after finalization of the test, the patient will be put on the IndiTreat® guided treatment. This is possible as the treatments tested are all approved by the health authorities.
Key benefits IndiTreat®
- Ability to provide patients with Individualized cancer treatments
- No time wasted on treatment decisions that will not benefit the patient
- Avoid tumor-resistance saves the patient from side-effects and society from wasted funds
- Implementing the IndiTreat® test is easy and will not disturb other oncology care processes
IndiTreat® will give caregivers the confidence that patients are treated individually to target their tumor most efficiently
IndiTreat® is available as a CE IVD Validated test.